AA
ALPS Advisors Portfolio holdings
AUM
$17.3B
This Quarter Return
+0.57%
1 Year Return
+13.43%
3 Year Return
+69.62%
5 Year Return
+161.48%
10 Year Return
+94.79%
AUM
$17.3B
AUM Growth
+$91.5M
(+0.53%)
Cap. Flow
+$341M
Cap. Flow
% of AUM
1.96%
Top 10 Holdings %
Top 10 Hldgs %
59.81%
Holding
1,066
New
76
Increased
460
Reduced
487
Closed
41
Top Buys
| 1 |
Hess Midstream
HESM
|
$100M |
| 2 |
Plains All American Pipeline
PAA
|
$99.4M |
| 3 |
Enterprise Products Partners
EPD
|
$41.5M |
| 4 |
Western Midstream Partners
WES
|
$32.9M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
$28.1M |
Top Sells
Sector Composition
| 1 | Energy | 68.28% |
| 2 | Technology | 4.29% |
| 3 | Financials | 3.4% |
| 4 | Consumer Discretionary | 2.95% |
| 5 | Materials | 2.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
926
HCA Healthcare
HCA
$95.4B
| $312K | ﹤0.01% |
815
-517
| -39% | -$198K |
|
927
Compañía de Minas Buenaventura
BVN
$5.06B
| $310K | ﹤0.01% |
18,890
+2,021
| +12% | +$33.2K |
|
928
Alcoa
AA
$8.05B
| $309K | ﹤0.01% |
10,456
+126
| +1% | +$3.72K |
|
929
Axalta
AXTA
$6.72B
| $308K | ﹤0.01% |
10,376
+126
| +1% | +$3.74K |
|
930
Starwood Property Trust
STWD
$7.44B
| $308K | ﹤0.01% |
15,344
-578
| -4% | -$11.6K |
|
931
Marriott International Class A Common Stock
MAR
$72B
| $304K | ﹤0.01% |
1,114
-627
| -36% | -$171K |
|
932
Coca-Cola Consolidated
COKE
$10.2B
| $304K | ﹤0.01% |
2,720
+30
| +1% | +$3.35K |
|
933
Xencor
XNCR
$594M
| $302K | ﹤0.01% |
38,399
-13,060
| -25% | -$103K |
|
934
The Greenbrier Companies
GBX
$1.42B
| $302K | ﹤0.01% |
6,549
+79
| +1% | +$3.64K |
|
935
Halozyme
HALO
$8.75B
| $299K | ﹤0.01% |
5,756
+70
| +1% | +$3.64K |
|
936
Theravance Biopharma
TBPH
$692M
| $298K | ﹤0.01% |
27,007
-9,072
| -25% | -$100K |
|
937
Eastman Chemical
EMN
$7.76B
| $298K | ﹤0.01% |
3,988
+48
| +1% | +$3.58K |
|
938
Schlumberger
SLB
$52.2B
| $297K | ﹤0.01% |
8,776
+106
| +1% | +$3.58K |
|
939
Molson Coors Class B
TAP
$9.85B
| $295K | ﹤0.01% |
6,124
+74
| +1% | +$3.56K |
|
940
Keros Therapeutics
KROS
$638M
| $293K | ﹤0.01% |
21,949
-7,787
| -26% | -$104K |
|
941
Willis Lease Finance
WLFC
$1.1B
| $292K | ﹤0.01% |
2,044
+74
| +4% | +$10.6K |
|
942
iShares MSCI India ETF
INDA
$9.29B
| $292K | ﹤0.01% |
5,239
-625
| -11% | -$34.8K |
|
943
Lantheus
LNTH
$3.75B
| $290K | ﹤0.01% |
3,544
+43
| +1% | +$3.52K |
|
944
Texas Pacific Land
TPL
$20.9B
| $289K | ﹤0.01% |
274
+3
| +1% | +$3.17K |
|
|
MAZE
945
Maze Therapeutics, Inc. Common Stock
MAZE
$666M
| $289K | ﹤0.01% |
+23,577
| New | +$289K |
|
946
Liquidity Services
LQDT
$824M
| $287K | ﹤0.01% |
12,157
+147
| +1% | +$3.47K |
|
|
ONL
947
Orion Office REIT
ONL
$167M
| $285K | ﹤0.01% |
133,625
+21,510
| +19% | +$45.8K |
|
948
Brown-Forman Class A
BF.A
$13.5B
| $284K | ﹤0.01% |
10,325
+125
| +1% | +$3.43K |
|
949
MiMedx Group
MDXG
$1.05B
| $283K | ﹤0.01% |
46,237
+1,547
| +3% | +$9.45K |
|
950
Regeneron Pharmaceuticals
REGN
$59.8B
| $281K | ﹤0.01% |
536
+6
| +1% | +$3.15K |
|